Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce it has signed an exclusive licence agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd.
Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, today announced it has successfully raised $2.2 million via a placement to institutional, sophisticated and professional investors.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce it will present its potential new blood test for endometriosis at the world's leading endometriosis conference.
Apiam Animal Health Limited (ASX:AHX) Managing Director Dr. Chris Richards outlines the Apiam brand and growing business, with veterinary practices joining the Apiam brand.
Proteomics International Laboratories Ltd (ASX:PIQ) in collaboration with Janssen Research & Development have shown that treatment with Canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce results showing a significant reduction in the PromarkerD risk scores of patients with type 2 diabetes after taking the diabetes medicine canagliflozin.
Bluechiip Limited (ASX:BCT) (FRA:1BL) Open Briefing with Managing Director, Andrew McLellan.
